Endoscopic Submucosal Dissection (ESD)

Part of paid clinical trials in Orlando, Florida.

Sponsor
AdventHealth
Study ID
NCT05468008
Status
Recruiting
Apply to this trial

Conditions

  • Barrett Esophagus
  • Esophageal Lesion
  • Gastrointestinal Lesions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Endoscopic Submucosal Dissection — PROCEDURE
    Endoscopic submucosal dissection (ESD) is an outpatient procedure to remove deep tumors from the gastrointestinal (GI) tract

Study Details

This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.

Key Dates

Start date
Feb 4, 2022
Status verified
Jan 2026
Primary completion
Feb 28, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Evaluate the utility of ESD for treatment of gastrointestinal lesions [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
AdventHealth OrlandoOrlandoFlorida32803
Dennis Yang, MD
[email protected]
407-303-2570

Find similar trials in Orlando, FL

By research site
AdventHealth Orlando· Orlando, FL

Related Studies